The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Diagnosis and Classification of Diabetes Mellitus
Abstract
DEFINITION AND DESCRIPTION OF DIABETES MELLITUSdDiabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of different organs, especially the eyes, kidneys, nerves, heart, and blood vessels. Several pathogenic processes are involved in the development of diabetes. These range from autoimmune destruction of the b-cells of the pancreas with consequent insulin deficiency to abnormalities that result in resistance to insulin action. The basis of the abnormalities in carbohydrate, fat, and protein metabolism in diabetes is deficient action of insulin on target tissues. Deficient insulin action results from inadequate insulin secretion and/or diminished tissue responses to insulin at one or more points in the complex pathways of hormone action. Impairment of insulin secretion and defects in insulin action frequently coexist in the same patient, and it is often unclear which abnormality, if either alone, is the primary cause of the hyperglycemia. Symptoms ofmarked hyperglycemia includepolyuria,polydipsia,weight loss,sometimes with polyphagia, and blurred vision. Impairment of growth and susceptibility to certain infections may also accompany chronic hyperglycemia. Acute, life-threatening consequences of uncontrolled diabetes are hyperglycemia with ketoacidosis or the nonketotic hyperosmolar syndrome. Long-term complications of diabetes include retinopathy with potential loss of vision; nephropathy leading to renal failure; peripheral neuropathy with risk of foot ulcers, amputations, and Charcot joints; and autonomic neuropathy causing gastrointestinal, genitourinary, and cardiovascular symptoms and sexual dysfunction. Patients with diabetes have an increased incidence of atherosclerotic cardiovascular, peripheral arterial, and cerebrovascular disease. Hypertension and abnormalities of lipoprotein metabolism are often found in people with diabetes. The vast majority of cases of diabetes fall into two broad etiopathogenetic categories (discussed in greater detail below). In one category, type 1 diabetes, the cause is an absolute deficiency of insulin secretion. Individuals at increased risk of developing this type of diabetes can often be identified by serological evidence of an autoimmune pathologic process occurring in the pancreatic islets and by genetic markers. In the other, much more prevalent category, type 2 diabetes, the cause is a combination of resistance to insulin action and an inadequate compensatory insulin secretory response. In the latter category, a degree of hyperglycemia sufficient to cause pathologic and functional changes in various target tissues, but without clinical symptoms, may be present for a long period of time before diabetes is detected. During this asymptomatic period, it is possible to demonstrate an abnormality in carbohydrate metabolism by measurement of plasma glucose in the fasting state or after a challenge with an oral glucose load or by A1C. The degree of hyperglycemia (if any) may change over time, depending on the extent of the underlying disease process (Fig. 1). A disease process may be present but may not have progressed far enough to cause hyperglycemia. The same disease process can cause impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) without fulfilling the criteria for the diagnosis of diabetes. In some individuals with diabetes, adequate glycemic control can be achieved with weight reduction, exercise, and/or oral glucose-lowering agents. These individuals therefore do not require insulin. Other individuals who have some residual insulin secretion but require exogenous insulin for adequate glycemic control can survive without it. Individuals with extensive b-cell destruction and therefore no residual insulin secretion require insulin for survival. The severity of the metabolic abnormality can progress, regress, or stay the same. Thus, the degree of hyperglycemia reflects the severity of the underlying metabolic process and its treatment more than the nature of the process itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
The Prednisolone Glucose Tolerance Test in Pregnancy
Kyle, G. C., Yalçin, S., Drewyer, R., & Carruthers, B. M. (1964) · Diabetes · doi:10.2337/diab.13.6.572 · Cited by 19
Cited by
Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643
Food Insecurity Is Associated with Chronic Disease among Low-Income NHANES Participants
Seligman, H. K., Laraia, B. A., & Kushel, M. B. (2010) · The Journal of Nutrition · doi:10.3945/jn.109.112573 · Cited by 1,640
Mechanism linking diabetes mellitus and obesity
Algoblan, A., Alalfi, M., & Khan, M. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s67400 · Cited by 1,028
Torloni, M. R., Betrán, A. P., Horta, B. L., Nakamura, M. U., Atallah, A. N., Moron, A. F., & Valente, O. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00541.x · Cited by 739
Global estimates of the prevalence of hyperglycaemia in pregnancy
Guariguata, L., Linnenkamp, U., Beagley, J., Whiting, D. R., & Cho, N. H. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.003 · Cited by 664
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Surrogate markers of insulin resistance: A review
Singh, B. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i2.36 · Cited by 622
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Pannala, R., Basu, A., Petersen, G. M., & Chari, S. T. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70337-1 · Cited by 558
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
Ellard, S., Bellanné-Chantelot, C., Hattersley, A. T., & European Molecular Genetics Quality Network (EMQN) MODY group (2008) · Diabetologia · doi:10.1007/s00125-008-0942-y · Cited by 433
The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., Filipponi, F., Weir, G. C., Eizirik, D. L., & Cnop, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0816-8 · Cited by 413
Shaham, O., Wei, R., Wang, T. J., Ricciardi, C., Lewis, G. D., Vasan, R. S., Carr, S. A., Thadhani, R., Gerszten, R. E., & Mootha, V. K. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.50 · Cited by 399
Mahmoud, A. M., Ashour, M. B., Abdel-Moneim, A., & Ahmed, O. M. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.001 · Cited by 374
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
Gao, L., & Mann, G. E. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp031 · Cited by 329
Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus
Al-Khawaldeh, O. A., Al-Hassan, M. A., & Froelicher, E. S. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.11.002 · Cited by 307
Type 1 Diabetes Mellitus in Pediatrics
Cooke, D. W., & Plotnick, L. (2008) · Pediatrics in Review · doi:10.1542/pir.29-11-374 · Cited by 290
Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes
Wilson, R. D., & Islam, M. S. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70739-9 · Cited by 289
Meyer, J. M., Davis, V. G., Goff, D. C., McEvoy, J. P., Nasrallah, H. A., Davis, S. M., Rosenheck, R. A., Daumit, G. L., Hsiao, J., Swartz, M. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.487 · Cited by 286
Kuo, L.-C., Polson, A. M., & Kang, T. (2008) · Public Health · doi:10.1016/j.puhe.2007.07.004 · Cited by 279
Ceriello, A., & Colagiuri, S. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02565.x · Cited by 268
Doupis, J., Lyons, T. E., Wu, S., Gnardellis, C., Dinh, T., & Veves, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2385 · Cited by 266
Pirkola, J., Pouta, A., Bloigu, A., Hartikainen, A.-L., Laitinen, J., Järvelin, M.-R., & Vääräsmäki, M. (2010) · Diabetes Care · doi:10.2337/dc09-1871 · Cited by 214
An integrative approach to health
Harris, K. M. (2010) · Demography · doi:10.1353/dem.0.0091 · Cited by 192
The hypoglycaemic effect of pumpkins as anti-diabetic and functional medicines
Adams, G. G., Imran, S., Wang, S., Mohammad, A., Kok, S., Gray, D. A., Channell, G. A., Morris, G. A., & Harding, S. E. (2011) · Food Research International · doi:10.1016/j.foodres.2011.03.016 · Cited by 175
Acute hyperglycemia and oxidative stress: Direct cause and effect?
Choi, S.-W., Benzie, I. F. F., Ma, S.-W., Strain, J. J., & Hannigan, B. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.005 · Cited by 149
Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells
Olivieri, F., Bonafè, M., Spazzafumo, L., Gobbi, M., Prattichizzo, F., Recchioni, R., Marcheselli, F., Sala, L. L., Galeazzi, R., Rippo, M. R., et al. (2014) · Aging · doi:10.18632/aging.100693 · Cited by 118
Friedman, J. E., Kirwan, J. P., Jing, M., Presley, L., & Catalano, P. M. (2008) · Diabetes · doi:10.2337/db07-1356 · Cited by 98
Alvarez-Guisasola, F., Yin, D. D., Nocea, G., Qiu, Y., & Mavros, P. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-86 · Cited by 78
Saad, A. M. J., Younes, Z. M. H., Ahmed, H., Brown, J. A., Al Owesie, R. M., & Hassoun, A. A. K. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.014 · Cited by 78
Vargas, V., Allende, H., Lecube, A., Salcedo, M. T., Baena-Fustegueras, J. A., Fort, J. M., Rivero, J., Ferrer, R., Catalán, R., Pardina, E., et al. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i12.382 · Cited by 69
Kang, M., Qin, W., Buya, M., Dong, X., Zheng, W., Lu, W., Chen, J., Guo, Q., & Wu, Y. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.031 · Cited by 63
Exercise interval training: an improved stimulus for improving the physiology of pre-diabetes.
Earnest, C. P. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.06.024 · Cited by 58
Subclinical Hypothyroidism has Little Influences on Muscle Mass or Strength in Elderly People
Moon, M. K., Lee, Y. J., Choi, S. H., Lim, S., Yang, E. J., Lim, J.-Y., Paik, N.-J., Kim, K. W., Park, K. S., Jang, H. C., et al. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.8.1176 · Cited by 48
Hermida, R. C., Ríos, M. T., Crespo, J. J., Moyá, A., Domínguez-Sardiña, M., Otero, A., Sánchez, J. J., Mojón, A., Fernández, J. R., Ayala, D. E., et al. (2013) · Chronobiology International · doi:10.3109/07420528.2012.701460 · Cited by 48
Andersson, C., Kolmodin, M., Ivarsson, S.-A., Carlsson, A., Forsander, G., Lindblad, B., Ludvigsson, J., Kockum, I., Marcus, C., Samuelsson, U., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12093 · Cited by 44
The role of first-trimester HbA1c in the early detection of gestational diabetes
Valadan, M., Bahramnezhad, Z., Golshahi, F., & Feizabad, E. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04330-2 · Cited by 43
KASAI, T., MIYAUCHI, K., KURATA, T., OKAZAKI, S., KAJIMOTO, K., KUBOTA, N., & DAIDA, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.235 · Cited by 28
(2009) · Paediatrics and Child Health · doi:10.1093/pch/14.2.79 · Cited by 18
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-01-01
- Volume
- 30
- Issue
- suppl_1
- Pages
- S42-S47
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4232138652
- Cited by
- 576
- References
- 4
- FWCI
- 34.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.